Enoxolone, also known as glycyrrhetinic acid, is a pentacyclic triterpenoid derivative primarily recognized for its anti-inflammatory, anti-ulcer, and antitussive properties. Derived from the hydrolysis… Read more
Enoxolone, also known as glycyrrhetinic acid, is a pentacyclic triterpenoid derivative primarily recognized for its anti-inflammatory, anti-ulcer, and antitussive properties. Derived from the hydrolysis of glycyrrhizic acid, it is used in both pharmaceutical and dermatological applications to address conditions such as peptic ulcers, respiratory tract inflammation, and various skin disorders. Laboratories utilize a comprehensive range of high-quality reference standards for this compound, including pharmacopeial and non-pharmacopeial impurities, to support rigorous pharmaceutical development. These compounds are essential for impurity profiling, allowing researchers to identify and quantify potential degradants or process-related byproducts during drug manufacturing. Furthermore, stable isotope labelled compounds are critical in analytical testing and method validation, providing internal standards for accurate mass spectrometry and other sensitive detection techniques. Together, these tools ensure consistent quality control and regulatory compliance throughout the lifecycle of enoxolone-based formulations.